TNFRSF4
Basic information
Region (hg38): 1:1211326-1214153
Previous symbols: [ "TXGP1L" ]
Links
Phenotypes
GenCC
Source:
- combined immunodeficiency due to OX40 deficiency (Limited), mode of inheritance: AR
- combined immunodeficiency due to OX40 deficiency (Supportive), mode of inheritance: AR
- combined immunodeficiency due to OX40 deficiency (Limited), mode of inheritance: Unknown
- combined immunodeficiency due to OX40 deficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Immunodeficiency 16 | AR | Allergy/Immunology/Infectious | Individuals may be susceptible to severe infections, as well as related oncologic sequelae (eg, Kaposi sarcoma), and early and aggressive treatment of infections and related sequelae may be beneficial | Allergy/Immunology/Infectious | 20156905; 23897980 |
ClinVar
This is a list of variants' phenotypes submitted to
- Combined_immunodeficiency_due_to_OX40_deficiency (309 variants)
- not_specified (47 variants)
- not_provided (19 variants)
- TNFRSF4-related_disorder (6 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003327.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 74 | 82 | ||||
| missense | 135 | 10 | 146 | |||
| nonsense | 0 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 9 | |||||
| splice donor/acceptor (+/-2bp) | 5 | |||||
| Total | 0 | 0 | 153 | 84 | 6 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TNFRSF4 | protein_coding | protein_coding | ENST00000379236 | 7 | 2813 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000151 | 0.682 | 124534 | 0 | 19 | 124553 | 0.0000763 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.623 | 142 | 164 | 0.863 | 0.0000110 | 1712 |
| Missense in Polyphen | 26 | 38.092 | 0.68256 | 467 | ||
| Synonymous | 0.163 | 73 | 74.8 | 0.976 | 0.00000549 | 583 |
| Loss of Function | 0.860 | 7 | 9.92 | 0.705 | 4.22e-7 | 130 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000157 | 0.000154 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000999 | 0.0000929 |
| European (Non-Finnish) | 0.000129 | 0.000125 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for TNFSF4/OX40L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity. {ECO:0000269|PubMed:7704935}.;
- Disease
- DISEASE: Immunodeficiency 16 (IMD16) [MIM:615593]: An autosomal recessive primary immunodeficiency associated with classic Kaposi sarcoma of childhood and poor T-cell recall immune responses due to complete functional OX40 deficiency. {ECO:0000269|PubMed:23897980}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Immune System;TNFs bind their physiological receptors;Downstream signaling in naïve CD8+ T cells
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.0863
- hipred
- N
- hipred_score
- 0.146
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.604
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnfrsf4
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; respiratory system phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- inflammatory response;immune response;cellular defense response;positive regulation of B cell proliferation;tumor necrosis factor-mediated signaling pathway;T cell proliferation;negative regulation of DNA-binding transcription factor activity;regulation of protein kinase activity;negative regulation of transcription, DNA-templated;viral entry into host cell;negative regulation of cytokine secretion;positive regulation of immunoglobulin secretion;negative regulation of activation-induced cell death of T cells;negative regulation of extrinsic apoptotic signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;external side of plasma membrane;cell surface
- Molecular function
- virus receptor activity;tumor necrosis factor-activated receptor activity;protein binding